Xycrobe Therapeutics Inc — Form D
Xycrobe Therapeutics Inc of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-20. The offering totals $1000K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-20
- Form: D
- Accession: 0001631127-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1000K
- Amount sold: $200K
- Remaining: $800K
- Investors: 1
- Date of first sale: 2015-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232534
Issuer
- Name: Xycrobe Therapeutics Inc
- CIK: 0001631127
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3210 MERRYFIELD ROW, SAN DIEGO, CA, 92121
- Phone: (858) 242-1529
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Thomas Hitchcock | Director | San Diego, CA |
| Thomas Hitchcock | Executive Officer | San Diego, CA |
More